1857-18-7

Usage

Uses

Used in Pharmaceutical Industry:
N~1~,N~1~-dimethyl-beta-alaninamide(SALTDATA: HCl) is used as a pharmaceutical intermediate for the synthesis of various drugs and medications. Its unique properties make it a valuable precursor in the production of pharmaceuticals, contributing to the development of new and innovative treatments.
Used in Drug Development:
N~1~,N~1~-dimethyl-beta-alaninamide(SALTDATA: HCl) is utilized as a precursor in the development of new drugs, thanks to its pharmacological properties. It may play a role in the creation of medications for the treatment of various health conditions and diseases, enhancing the therapeutic options available to patients.

Upstream product

• 7391-40-4 N,N-dimethylcyanoacetamide 
• 154656-93-6 tert-butyl N-[3-(dimethylamino)-3-oxo-propyl]carbamate 
• 23159-09-3 N',N'-dimethyl-N-carbobenzoxy-β-alaninamide 

Downstream Products

• 439933-46-7 3-{2-[1-(3,4-Dimethoxy-benzyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-benzo[c]azepin-2-yl]-2-phenyl-acetylamino}-N,N-dimethyl-propionamide 

Relevant academic research and scientific papers

INHIBITION OF OLIG2 ACTIVITY

Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.

INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE

Compounds of formula (I) in free or salt form, wherein R1, R2, R3, and R4 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by mediated by phosphatidylinos

Indole derivatives as 5-HT1-like agonists for use in migraine

The present invention relates to 3,5-disubstituted indole compounds which are selective agonists which act on 5-hdroxytryptamine receptors useful in the treatment of migraine.